Figure 1From: Long-term results of treatment with bosentan in adult Eisenmenger’s syndrome patients with Down’s syndrome related to congenital heart disease 6-minute walk distance (6MWD), peak exercise transcutaneous arterial oxygen saturation (SpO 2 ) before and at the end of the 6-minute walk test at baseline and a. Month 24 and b. Last visit Back to article page